The move: Gilead Sciences dropped 2.52% in premarket trading, falling to $107.45 per share Wednesday morning. The biopharmaceutical company is up 19.34% for the year. Why: The stock's decline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback